Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clarity Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Race Oncology blows past dosing stage of Phase 1, targets Phase 2
News
Closing Bell: ASX microcaps lead the way in a war zone as US futures swing lower
Health & Biotech
ASX Health Stocks: Results show revenue is growing in first half, but profitability still elusive
Experts
Twenty-One of the Best: Tim Boreham’s Hot Stocks for 2022
Health & Biotech
ASX Health Stocks: Alterity moves to Phase 2 on cancer drug, Race Oncology secures 6th US patent
Health & Biotech
Dr Boreham’s Crucible: With five trials and $100m, cancer-hunter Clarity’s future is clear
News
ASX Capital Raise Roundup: Keep calm (through lockdowns) and carry on!
IPO Watch
